Editorial: Improving outcomes for primary and salvage therapy of localized prostate cancer

Journal of Urology

Volumn 170, Issue 5, 2003, Pages 1841-1842

  Schellhammer, Paul F ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPROMAB PENDETIDE IN 111; PROSTATE SPECIFIC ANTIGEN;

BRACHYTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; EDITORIAL; HUMAN; INTESTINE FUNCTION; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; TREATMENT OUTCOME;

EID: 0141885288     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000092223.19256.6b     Document Type: Editorial

References (2)

1. Glatstein, E.: Intensity-modulated radiation: the inverse, the converse, and the perverse. Sem Rad Oncol, 12: 272, 2002
2. Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S., Miller, G. J., Ford, L. G. et al: The influence of finasteride on the development of prostate cancer. N Engl J Med, 349: 215, 2003